Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Lilly Japan Sales Up 7% in 2017, Upbeat Biz Fueled by Global Simultaneous Development
March 23, 2018
- Eldecalcitol NDA Accepted in China: Chugai
March 23, 2018
- J-TEC’s Cell Sheet JACE Filed for Epidermolysis Bullosa
March 23, 2018
- EA Pharma, Irish Cosmo Technologies Hook Up on Colonoscopy Products
March 23, 2018
- Single Generic Pricing Rule Will Accelerate Unreasonable Price Raises: Sawai Chief
March 22, 2018
- Takeda Global Headquarters Completed
March 22, 2018
- Mircera 12.5μg Version Approved in Japan: Chugai
March 22, 2018
- Life Science Institute to Launch Cell Processing Center for Muse Cells, Aiming to Commence Operations in Jan. 2019
March 22, 2018
- Toho Forms Capital Alliance with Tokyo Upstart HekaBio
March 20, 2018
- Hitachi Chemical Wins Clinical Regenerative Medicine Manufacturing Deal from Daiichi Sankyo
March 20, 2018
- Opdivo Picks Up HCC Nod in Taiwan
March 20, 2018
- Top Court Slaps Down Debiopharm’s Appeal over Elplat Patent
March 20, 2018
- Xtandi Gets FDA Priority Review Status for Add’l CRPC Indication
March 20, 2018
- IBL, Astellas Wind Up Human Fibrinogen Collaboration
March 20, 2018
- Bioverativ Earns Approval for 4,000 IU Version for Hemophilia B Treatment Alprolix
March 20, 2018
- Toho to Thoroughly Implement Drug Distribution GL, Focus on Cost-Cutting in Response to Impact of Drug Pricing Reform: Pres.
March 20, 2018
- Takeda Bolstering Pitch for Inisync, Takecab in December: Anterio Ranking
March 19, 2018
- Ethical Drug Sales Up 3.6% in January on AbbVie Hep C Drug, Seasonal Factors
March 19, 2018
- EMA Accepts Filing for Xtandi’s CRPC Label Expansion
March 19, 2018
- Shionogi Nabs Rights to Osaka Upstart’s Tissue Regeneration-Inducing Peptide
March 16, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…